INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $7,000 | -22.2% | 16,446 | +3.5% | 0.00% | – |
| Q1 2018 | $9,000 | -30.8% | 15,894 | -2.0% | 0.00% | – |
| Q4 2017 | $13,000 | – | 16,214 | +135016.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 12 | -98.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 596 | -16.2% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 711 | +18.9% | 0.00% | – |
| Q4 2016 | $2,000 | +100.0% | 598 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -98.6% | 598 | -98.7% | 0.00% | – |
| Q2 2016 | $72,000 | +7100.0% | 46,098 | +7608.7% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 598 | -33.5% | 0.00% | – |
| Q4 2015 | $2,000 | 0.0% | 899 | -0.8% | 0.00% | – |
| Q3 2015 | $2,000 | +100.0% | 906 | +195.1% | 0.00% | – |
| Q2 2015 | $1,000 | 0.0% | 307 | -0.3% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 308 | +2.0% | 0.00% | – |
| Q4 2014 | $1,000 | – | 302 | +30100.0% | 0.00% | – |
| Q3 2014 | $0 | – | 1 | -98.6% | 0.00% | – |
| Q2 2014 | $0 | – | 69 | +1625.0% | 0.00% | – |
| Q1 2014 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2013 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST FOUNDATION ADVISORS | 98,600 | $202,000 | 0.02% |
| Atria Investments, Inc | 65,439 | $134,000 | 0.02% |
| Argent Trust Co | 15,121 | $31,000 | 0.02% |
| Stonehage Fleming Financial Services Holdings Ltd | 2,060 | $170,000 | 0.01% |
| Acrospire Investment Management LLC | 2,100 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,444 | $7,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,421 | $7,000 | 0.00% |
| 1832 Asset Management L.P. | 10,012 | $20,000 | 0.00% |